HCPLive

NOVEMBER 25, 2024

Hypovitaminosis D was more prevalent in patients with lupus nephritis compared to patients with systemic lupus erythematosus without kidney disease.

Kidney Disease 116

Kidney Disease 116

Journal of Clinical Investigation - Cardiology

OCTOBER 1, 2024

of cases, a qualifying potentially disease-causing rare variant in an established gene was found.

Kidney Disease 119

Kidney Disease Research 119

HCPLive

SEPTEMBER 18, 2024

The new guidance reviews existing tools for weight management and provides recommendations for their use in clinical practice in patients with obesity and kidney disease.

Kidney Disease 105

Kidney Disease Obesity 105

HCPLive

SEPTEMBER 20, 2024

Nehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.

Kidney Disease 105

Kidney Disease 105

HCPLive

MAY 17, 2024

Check out this quiz on the NKF's KDOQI recommendations on nutrition in chronic kidney disease, with a focus on their guidance for protein and energy intake!

Kidney Disease 105

Kidney Disease 105

HCPLive

FEBRUARY 2, 2024

Obesity was linked to an increased risk of focal segmental glomerulosclerosis and hypertensive nephropathy, with further analysis revealing its impact on the risk of developing end-stage kidney disease.

Kidney Disease 106

Kidney Disease Obesity Hypertension 106

Journal of Clinical Investigation - Cardiology

MARCH 1, 2024

Two coding variants of apolipoprotein L1 (APOL1), called G1 and G2, explain much of the excess risk of kidney disease in African Americans. While various cytotoxic phenotypes have been reported in experimental models, the proximal mechanism by which G1 and G2 cause kidney disease is poorly understood.

Kidney Disease 102

Kidney Disease 102

HCPLive

JANUARY 23, 2024

Findings from the retrospective cohort study suggest an increased prevalence of advanced kidney disease among individuals with Crohn disease and ulcerative colitis.

Kidney Disease 106

Kidney Disease 106

HCPLive

APRIL 17, 2024

The consensus calls for the recognition of kidney disease as a major non-communicable disease driver of premature mortality by the World Health Organization.

Kidney Disease 98

Kidney Disease 98

Med Page Today

JANUARY 4, 2024

(MedPage Today) -- SGLT2 inhibitors significantly lowered the risk of death, major adverse kidney events (MAKE), and major adverse cardiovascular events (MACE) in people with type 2 diabetes and acute kidney disease, according to a cohort study.

Kidney Disease 105

Kidney Disease Diabetes 105

HCPLive

DECEMBER 14, 2023

Microbiota-based interventions may be a novel strategy to benefit the mitigation of chronic kidney disease advancement.

Kidney Disease 98

Kidney Disease 98

HeartRhythm

FEBRUARY 6, 2025

Limited evidence supports apixaban's use for atrial fibrillation (Af) in severe chronic kidney disease (CKD) or end-stage kidney disease (ESKD) patients, where warfarin is often contraindicated.

Kidney Disease 74

Kidney Disease Atrial Fibrillation 74

Med Page Today

FEBRUARY 14, 2025

(MedPage Today) -- The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk patients with type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular risk factors, a prespecified.

Kidney Disease 76

Kidney Disease Heart Attack Heart attacks Diabetes 76

HCPLive

JANUARY 4, 2024

Compared to nonusers, patients with type 2 diabetes and acute kidney disease administered SGLT-2is had a significantly lower risk of mortality, major adverse kidney events, and major adverse cardiovascular events.

Kidney Disease 105

Kidney Disease Diabetes 105

HCPLive

JANUARY 28, 2025

The FDA approved semaglutide to reduce the risk of kidney disease worsening, kidney failure, and death due to CVD in those with T2D and CKD.

Kidney Disease 76

Kidney Disease Diabetes 76

American Heart News - Heart News

MARCH 21, 2024

Research Highlights: A study of nearly 4 million young adults under age 40 in South Korea found that those who had ideal cardiovascular health were nearly two-thirds less likely to develop heart disease, stroke and/or kidney disease during a 12-year.

Kidney Disease 95

Kidney Disease Heart Disease Stroke Strokes 95

Cardiovascular Diabetology

FEBRUARY 14, 2025

People living with diabetes mellitus (DM) and chronic kidney disease (CKD) are at significantly high risk of cardiovascular events (CVEs), however the predictive performance of traditional risk prediction meth.

Kidney Disease 76

Kidney Disease Diabetes Research 76

Medical Xpress - Cardiology

DECEMBER 19, 2023

Heart failure is causally associated with chronic kidney disease (CKD), according to a study published online Dec. 11 in PLOS ONE.

Kidney Disease 75

Kidney Disease Heart Failure 75

Journal of Clinical Investigation - Cardiology

FEBRUARY 15, 2024

Worldwide, over 800 million people are affected by kidney disease, yet its pathogenesis remains elusive, hindering the development of novel therapeutics. Lipid accumulation and the expression of genes related to DNL were elevated in the kidneys of patients with fibrosis.

Kidney Disease 81

Kidney Disease Pharmacology Ablation 81

HCPLive

FEBRUARY 12, 2025

In the final segments of this 4-part episode, the discussion focuses on the use of HCEs in different kidney disease trials.

Kidney Disease 59

Kidney Disease 59

HCPLive

MAY 20, 2024

A numerically slower decline in eGFR was reported in the finerenone cohort after hospitalization for heart failure when compared with placebo.

Heart Failure 116

Heart Failure Kidney Disease Hospital 116

HCPLive

MAY 29, 2024

Brendon Neuen, MBBS, PhD, joins the podcast to discuss the latest updates in nephrology, including the landmark FLOW trial.

Kidney Disease 135

Kidney Disease 135

HCPLive

OCTOBER 26, 2024

The dapagliflozin group had an average eGFR rate of -2.24 mL/min/1.73 m2 compared to -3.67 mL/min/1.73 m2 in the control group after about 1.5 years of follow-up.

Kidney Disease 111

Kidney Disease 111

HCPLive

JULY 25, 2024

The sNDA for furosemide seeks to expand the indication to include the treatment of edema due to fluid overload in patients with CKD, with a PDUFA date of March 6, 2025.

Kidney Disease 111

Kidney Disease 111

Journal of Clinical Investigation - Cardiology

FEBRUARY 15, 2024

Ten percent of the population worldwide suffers from chronic kidney disease (CKD), but the mechanisms driving CKD pathology are incompletely understood. Identify acyl-CoA synthetase short-chain family 2 (ACSS2) as a disease risk gene and demonstrate a role for ACSS2 in de novo lipogenesis (DNL).

Kidney Disease 67

Kidney Disease Pharmacology 67

HCPLive

MAY 27, 2024

An analysis of more than 800 IgAN patients treated from 2002-2021 provides an overview of factors associated with anmeia as well as its impact on pgronosis.

Kidney Disease 112

Kidney Disease 112

HCPLive

JULY 23, 2024

Spigler provides insight into the development of new patient-focused guidelines for managing hyperkalemia in CKD and the importance of providing patients with such resources.

Kidney Disease 111

Kidney Disease Education 111

HCPLive

NOVEMBER 13, 2024

People with diabetes, kidney stones, damaged joints, high uric acids, and daily use of NSAID were more likely to develop CKD than others.

Kidney Disease 106

Kidney Disease Diabetes 106

Medical Xpress - Cardiology

FEBRUARY 14, 2025

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.

Heart Attack 138

Heart Attack Heart attacks Research Kidney Disease 138

HCPLive

MARCH 26, 2024

A study in China identified a negative and non-linear relationship between hemoglobin levels and a renal composite end point in patients with DKD.

Kidney Disease 98

Kidney Disease Diabetes Outcomes 98

HCPLive

DECEMBER 21, 2023

A new study is raising awareness around the effects of structural racism on the prevalence of chronic health conditions.

Kidney Disease 122

Kidney Disease Cardiovascular Disease Diabetes 122

Journal of the American Heart Association

FEBRUARY 16, 2024

BackgroundInhibition of prostaglandin synthesis by nonsteroidal anti‐inflammatory drugs is associated with cardiovascular mortality and kidney disease. Future studies should address whether these associations are causal and can be targeted to improve cardiovascular and kidney outcomes.

Kidney Disease 73

Kidney Disease Risk Factors Diabetes Outcomes 73

HCPLive

MAY 18, 2024

Wei Ling Lau, MD, explains the importance of medication adherence to maximize the benefits of RAASi therapy.

Kidney Disease 116

Kidney Disease 116

HCPLive

APRIL 26, 2024

A higher TRV was significantly associated with cerebrovascular disease and persistent albuminuria in children with SCD across two large cohorts.

Kidney Disease 98

Kidney Disease Cerebrovascular Disease Tricuspid 98

HCPLive

DECEMBER 13, 2024

Matthew Weir, MD discusses how a multidisciplinary approach is reshaping CKD management, with a focus on mitigating cardiovascular events.

Kidney Disease 97

Kidney Disease 97

HCPLive

DECEMBER 14, 2023

These results highlight the potential of preventing increasing CKD burden and of preventing subsequent cardiovascular conditions, especially given current rates of obesity among adolescents.

BMI 105

BMI Kidney Disease Obesity 105

Journal of Clinical Investigation - Cardiology

SEPTEMBER 3, 2024

The development of AAV2-GEC and its successful application in the treatment of antibody-mediated kidney disease represents a significant step forward and opens up promising avenues for kidney medicine. Taken together, this study showcases the potential of AAV as a gene delivery platform for challenging cell types.

Kidney Disease 63

Kidney Disease 63